I am trying to build a transit compartment model to fit the plasma PK with two peaks especially at high dose groups. It is reported that transit compartment is a good choose. I add a transit statement. But unfortunately couldn’t fit data. No effect was observed when I tried to adjust mtt, ktr and ntr. Sounds like there is a glitch.
It will be appreciated if you can help in fitting the PK data to transit compartment model. I am attaching project file with existing mode for only high dose PK.
i think it will be more informative if you fit all the data you have i.e. with the different dose levels. I will try to take a look at your project at the week end. Simon.
Had a quick look at your project file and looks like this is not a Transit model. I have attached a link to a YouTube/PML school on enterohepatic circulation and hope this should be useful for you. From the forum, you could download the PML code for your reference.
Obviously wrong, you need to give At1 an initial value, which needs to be done through the dosepoint() statement.
like:
dosepoint(At1)
But in order to distinguish it from the original Aa and share the same total dose, you’d better add another bioavailability parameter F.
So:
dosepoint(Aa, bioavail = (f))
dosepoint(At1, bioavail = (1-f))
fixef(f = c(, 0.5, ))mouse PK_fyc.phxproj (3.83 MB)
Thanks Chanramouli for your feedback and forwarding PML code, Agree, enterohepatic re-circulation is an option for modeling this kind of double peak PK. I did create a model. It fit the data.
Thank you so much for your help! Having two parts of dosepoint statement with bio-availability parameter makes much sense and is simple for transit compartment. Thanks for the coding as well.
I tried to use this transit model to fit three dose PK. Sounds like model fit 100 mg and 200 mpk dose well, but not on 30 mpk. I did minor modification by adding saturable absorption and elimination based on attached paper. Author emphasized that this model can describe PK with late absorption peak at HIGHER doses (that is exactly my case here). But it is no significant improvement on my case. Model showed second peak on low dose 30 mpk. Paper and my project are attached. Do you have any suggestions?
a major problem with the models in your project file is that they have too many parameters, only a small fraction of the parameters seems to be identifiable. That is why I am thinking that the idea of a transit model does not fit here.
There is one additional alternative to the transit model that you are in favor of:
In one of our PML School we presented a scenario with sublingual dosing. At first sight, this might not be related to your model, however, it describes a similar scenario: